The Arab Pesticides & Veterinary Drugs Mfg. Co. (ASE:MBED)

ASE:MBED Balance Sheet

Financials in millions JOD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.62	6.94	8.2	4.48	4.01	3.73
Cash & Short-Term Investments	8.62	6.94	8.2	4.48	4.01	3.73
Cash Growth	27.15%	-15.43%	83.06%	11.77%	7.61%	23.32%
Accounts Receivable	19.39	17.55	16.3	16.09	12.72	11.43
Other Receivables	0.19	0.47	0.48	0.11	0.15	0.12
Receivables	19.58	18.02	16.78	16.2	12.87	11.55
Inventory	18.38	18.04	17	15.11	15.31	11.92
Prepaid Expenses	-	0.45	0.45	0.37	0.35	0.31
Other Current Assets	4.69	3.34	1.42	1.19	0.58	0.38
Total Current Assets	51.28	46.78	43.85	37.36	33.11	27.89
Property, Plant & Equipment	15.93	13.51	12.37	10.07	7.75	6.68
Long-Term Investments	1.22	0.99	0.87	0.72	0.71	0.8
Long-Term Accounts Receivable	0.04	-	-	-	0.02	0.06
Total Assets	68.48	61.27	57.1	48.15	41.59	35.43

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.37	1.83	2.19	1.67	2.29	0.87
Accrued Expenses	-	0.82	0.76	0.68	0.97	0.93
Short-Term Debt	-	2.57	-	-	-	1.16
Current Portion of Long-Term Debt	5.02	2.31	4.35	2.5	3.03	0.17
Current Income Taxes Payable	-	0.35	0.52	0.32	0.28	0.35
Other Current Liabilities	2.75	0.53	0.64	0.76	0.59	0.53
Total Current Liabilities	12.14	8.41	8.46	5.93	7.15	4.02
Long-Term Debt	2.53	2.57	2.86	1.66	1.06	1.61
Other Long-Term Liabilities	0.57	0.57	0.52	0.56	0.25	-
Total Liabilities	15.23	11.55	11.85	8.15	8.46	5.63

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	20	16.5	16.5	16.5	15	15
Additional Paid-In Capital	1.5	1.5	1.5	1.5	-	-
Retained Earnings	24.82	25.84	21.62	17.57	14.59	11.89
Comprehensive Income & Other	-3.19	-3.15	-3.1	-3.01	-2.77	-2.51
Total Common Equity	43.14	40.69	36.52	32.56	26.82	24.38
Minority Interest	10.11	9.03	8.73	7.44	6.31	5.42
Shareholders' Equity	53.24	49.72	45.25	40	33.13	29.8
Total Liabilities & Equity	68.48	61.27	57.1	48.15	41.59	35.43

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	7.56	7.45	7.22	4.16	4.09	2.94
Net Cash (Debt)	1.07	-0.51	0.99	0.32	-0.08	0.78
Net Cash Growth	-	-	207.68%	-	-	-
Net Cash Per Share	0.05	-0.03	0.05	0.02	-0.00	0.04
Filing Date Shares Outstanding	20	20	20	20	18.18	18.18
Total Common Shares Outstanding	20	20	20	20	18.18	18.18
Working Capital	39.14	38.36	35.39	31.43	25.96	23.87
Book Value Per Share	2.16	2.03	1.83	1.63	1.48	1.34
Tangible Book Value	43.14	40.69	36.52	32.56	26.82	24.38
Tangible Book Value Per Share	2.16	2.03	1.83	1.63	1.48	1.34
Land	-	1.57	1.57	1.53	1.53	0.92
Buildings	-	6.21	6.06	6.01	5.95	5.89
Machinery	-	9.29	8.81	7.87	7.66	7.15
Construction In Progress	-	4.63	3.71	2.44	0.08	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error